Healthcare Services

Growing Aging Population Boost Somatostatin Analogs Market Continues To Impact The Growth Of The Somatostatin Analogs Market

June 3, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Somatostatin Analogs Market Progress Through 2030?

The somatostatin analogs market has seen significant growth over recent years. Projections indicate it will expand from $7.16 billion in 2025 to reach $7.66 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. This historical growth is attributable to factors such as an increase in neuroendocrine tumor diagnoses, the prevalence of hormone disorders, compelling clinical efficacy evidence, specialist prescribing practices, and improved hospital access.

The somatostatin analogs market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $10.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the projection period include the introduction of biosimilars, broadened indications, an increase in the aging population, enhanced diagnosis rates, and specialty drug reimbursement. Key trends expected within the forecast timeframe encompass the rising prevalence of long-acting injectables, extended neuroendocrine tumor indications, a greater emphasis on improving patient compliance, continued biosimilar development, and an increase in hospital-based therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10840&type=smp

Which Strategic Drivers Are Supporting The Somatostatin Analogs Market Development?

The expanding aging demographic is projected to boost the growth of the somatostatin analogs market. An aging population indicates a demographic shift characterized by a higher proportion or an increasing count of individuals in a society who are aged 65 years and older. This rise in the elderly population correlates with a greater incidence of diseases that necessitate the use of Somatostatin Analogs, thus stimulating demand for these pharmaceuticals. For instance, in July 2024, information from the UK Parliament’s House of Commons Library revealed that in 2022, there were 12.7 million people aged 65 or older in the UK, accounting for 19% of the total population. This figure is forecast to reach 22.1 million by 2072, representing 27% of the population. Therefore, the increasing aging population is a primary driver for the growth of the somatostatin analogs market.

How Does Segment Analysis Break Down The Somatostatin Analogs Market Structure?

The somatostatin analogs market covered in this report is segmented –

1) By Type: Octreotide, Lanreotide, Pasireotide

2) By Treatment: Acromegaly, Cushing’s Syndrome, Neuroendocrine Tumors, Carcinoid Syndrome, Other Treatments

3) By End User: Hospital, Pharmaceutical Companies

Subsegments:

1) By Octreotide: Long-Acting Release (LAR) Formulations, Short-Acting Formulations

2) By Lanreotide: Depot Formulations, Injectable Formulations

3) By Pasireotide: Long-Acting Injectable Formulations, Subcutaneous Formulations

Which Trends Are Supporting The Evolution Of The Somatostatin Analogs Market?

Leading firms within the solid tumor testing market are concentrating on creating breakthroughs, particularly liquid biopsy platforms designed for solid tumor analysis. This platform involves diverse technologies and systems for examining body fluids, most commonly blood, to detect biomarkers associated with cancer. An example of this is PrognomiQ, a US-based healthcare company, which introduced its multi-omics liquid biopsy platform in January 2023. The subsequent stage of PrognomiQ’s product advancement commenced with the launch of a prospective clinical program involving 15,000-subject, with the initial patient already enrolled. The driving force behind this endeavor was the capability of multi-omics markers to differentiate between cancerous conditions and healthy controls.

Which Companies Are Engaged In The Somatostatin Analogs Market Environment?

Major companies operating in the somatostatin analogs market are Novartis International AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Midatech Pharma plc, Crinetics Pharmaceuticals Inc., Peptron Inc., Teva Pharmaceutical Industries Ltd., Camurus AB, Bayer Aktiengesellschaft, Cadila Healthcare Limited, Amneal Pharmaceuticals Inc., Recordati S.p.A., Amryt Pharma plc, Ipsen Pharma SA, Fresenius Kabi AG, Chiasma Inc., Merck KGaA, Sanofi S.A., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Viatris Inc., AstraZeneca plc, Johnson & Johnson, Genentech Inc., OctreoPharm Sciences GmbH

Access The Complete Somatostatin Analogs Market Report:

https://www.thebusinessresearchcompany.com/report/somatostatin-analogs-global-market-report

Which Region Accounts For The Highest Share Of The Somatostatin Analogs Market?

North America was the largest region in the global somatostatin analogs treatment market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatostatin analogs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Somatostatin Analogs Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10840&type=smp

Browse Through More Reports Similar to the Global Somatostatin Analogs Market 2026, By The Business Research Company

Sorbitol Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/sorbitol-global-market-report

Aspirin Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aspirin-global-market-report

Sorbates Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/sorbates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795